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In some previous investigations, the similar sized aneurysms were
defined as “giant” or “large” (1-5). So, we think there are subjective 
opinions about the definition of aneurysm size in the literature.
Thanks to author for their interest to our case.
Mehmet Çak›c›, 
Department of Cardiovascular Surgery, 
Faculty of Medicine, Ankara University,
Dikimevi, Ankara, Turkey
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Incomplete Kawasaki disease: 
a pediatric diagnostic conflict
‹nkomplet Kawasaki hastal›¤›: 
Pediatrik tan›sal zorluk
Dear Editor,
We read with interest the article "Incomplete Kawasaki disease: a
pediatric diagnostic conflict" by Çelik et al (1). They reported two children
with incomplete Kawasaki disease (KD) who responded to 2 g/kg single
dose intravenous immunoglobulins (IVIG) and 3 mg/kg aspirin (1). 
Sonobe et al. (2) recently reported that the coronary artery 
abnormality (CAA) prevalence of incomplete KD (18.4%) was higher than
that of complete KD (14.2%) among 15,857 cases with KD (83.9% 
complete KD and 16.1% incomplete KD) using the data from the 17th 
Japanese nationwide survey of KD. Because late diagnosis of KD 
increases the risk for coronary artery abnormalities, Minich et al. (3) 
also recently suggested that clinicians should maintain a high index of
suspicion of KD in the infant who is younger than 6 months and has 
prolonged fever even with incomplete criteria. Nevertheless, it is not
easy to suspect KD at an early stage of the disease. 
Therefore, Sinha et al. reported that erythema at the site of BCG 
inoculation might be a useful diagnostic tool even for incomplete KD (4).
Using this phenomenon, we previously diagnosed and reported a 
9-week-old male infant with incomplete KD who was initially treated with
high-dose IVIG (2 g/kg) and oral aspirin (100 mg/kg) (5). Initial echocar-
diography was normal in this patient, but a giant aneurysm of right 
coronary artery (RCA) was newly developed one week later. Intravenous
dexamethasone and oral methotrexate were given due to rapidly 
progressive coronary artery aneurysm, but those treatments were not 
effective. On 38th hospital day, we performed coronary angiography,
which demonstrated multiple giant aneurysms with sluggish blood flow
on the entire RCA and a stenosis on the proximal anterior descending
branch of the left coronary artery. Because he had had a prolonged 
course of severe coronary involvement refractory to intensive medical
therapies, surgical intervention, such as plication of dilated coronary 
artery, was tried. However, the patient died from acute cardiorespiratory
failure shortly after weaning from cardiopulmonary bypass (5). 
Although there has been no effective therapy in patients with 
incomplete KD resistant to IVIG and aspirin, one of our authors previously
reported the beneficial effect of low-dose oral methotrexate on 4 
patients with Kawasaki disease (age 8 months - 8 years) resistant to IVIG
(6). However, methotrexate could not cease the rapid progression of 
coronary artery aneurysm associated with incomplete KD in our young
patient (5). 
The diagnosis of Kawasaki disease in very young infants is often 
difficult because of its rarity and atypical presentation. Although BCG 
reactivation may help us to suspect incomplete KD at an early stage of
the disease, CAA can develop within a relatively short time in contrast to
the patients of Çelik et al. (1). Therefore, not only early diagnosis but also
more aggressive therapy will be important to prevent sudden cardiac 
death in incomplete KD and further studies should be performed to 
elucidate the epidemiology and natural course of incomplete KD in 
different ethnic populations.
Jae Il Shin, Byung Won Yoo, Dong Soo Kim, Jae Young Choi
Cardiovascular Research Institute, Department of Pediatrics, 
Yonsei University College of Medicine, 
Severance Children’s Hospital, Seoul, Korea
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Author’s reply
Dear Editor,
In Kawasaki disease (KD) early diagnosis and specific treatment is 
essential to avoid mortality. As the authors emphasize, Kawasaki disease
is a still diagnostic dilemma for pediatricians, especially with it’s atypical
or incomplete presentations. Recently, the patients who does not fit the
fulfill criteria were considered as incomplete or atypical Kawasaki by the
specific signs and exclusion of other causes as we discussed before (1).
Independent predictors were well-defined in KD (2). They have 
included protracted fever, presumably reflecting worse vasculitis, 
anemia, elevated white blood count, low albumin, elevated C-reactive 
protein, male gender and age younger than 1 year (2). As we understood
from the author’s case, the patient had at least two risk factors (early age
and male gender). 
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There are few randomized trials to guide therapy of the child in whom
fever continues or recurs despite initial therapy with IVIG. In a 
retrospective review of coronary risk factors among KD patients treated
with additional IVIG, the number of days of fever before initiation IVIG 
re-treatment was an independent predictor of coronary artery abnormality (3).
Although randomized trials are lacking most experts believe that 
children who are febrile, without other explanation, >36 hours after 
completion of first IVIG infusion should be retreated with IVIG. For children
who defervesce with a second IVIG infusion but in whom fever recurs, a
third IVIG infusion or alternatively intravenous methylprednisolone 30
mg/kg may be considered (4).
On the other hand, the authors discussed that erythema at the site of
BCG inoculation might be a useful diagnostic tool even for incomplete KD.
We agree with this opinion. Also, there are some reports about this issue
in the literature (5). Clinicians should be aware of this clinical 
manifestation that could help diagnose incomplete Kawasaki disease. 
We thank authors for attention to our report.
Ümit Çelik, Emre Alhan, Nazan Özbarlas*
From Departments of Pediatric Infection and *Pediatric Cardiology, 
Faculty of Medicine, Çukurova University, Adana, Turkey 
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